Neuronostatin acts via GPR107 to increase cAMP-independent PKA phosphorylation and proglucagon mRNA accumulation in pancreatic α-cells. [electronic resource]
- American journal of physiology. Regulatory, integrative and comparative physiology Jan 2016
- R143-55 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural
1522-1490
10.1152/ajpregu.00369.2014 doi
Animals Cell Line Cyclic AMP--metabolism Cyclic AMP-Dependent Protein Kinases--metabolism Glucagon-Secreting Cells--drug effects Humans Male Mice Peptide Fragments--metabolism Peptide Hormones--metabolism Phosphorylation Proglucagon--genetics RNA Interference RNA, Messenger--genetics Rats, Sprague-Dawley Receptors, G-Protein-Coupled--agonists Signal Transduction--drug effects Somatostatin--metabolism Transfection Up-Regulation